About Us
About Us
KinesisDx: Precision, Innovation, and Reliability in Antibody Development
KinesisDx is a premier manufacturer of high-performance primary antibodies, dedicated to advancing biomedical research through precision-driven antibody solutions. Headquartered in the US, our team of experienced scientists and antibody engineers work tirelessly to deliver products that meet the highest standards of quality and reproducibility.
Our Mission
At KinesisDx, we are committed to empowering researchers by providing meticulously validated antibodies designed to accelerate scientific breakthroughs. Our mission is to drive advancements in immunology, oncology, neuroscience, infectious diseases, and beyond by ensuring that researchers have access to the most reliable and reproducible antibody reagents.
Our Expertise
With expertise in hybridoma technology, recombinant antibody engineering, and antigen-specific immunization strategies, we develop monoclonal, polyclonal, and recombinant antibodies optimized for a broad spectrum of applications, including:
- Western Blotting (WB)
- Immunohistochemistry (IHC)
- Flow Cytometry (FC)
- ELISA & Multiplex Assays
- Immunoprecipitation (IP) & Chromatin Immunoprecipitation (ChIP)
- Immunofluorescence (IF) & High-Throughput Screening
Why Researchers Trust KinesisDx
- Unmatched Specificity & Sensitivity: Our antibodies undergo rigorous validation across multiple applications to ensure reproducibility.
- Extensive Catalog: We offer a diverse portfolio of antibodies for various research areas, with new products continually developed.
- Lot-to-Lot Consistency: Our proprietary production methods ensure high batch-to-batch reproducibility, reducing experimental variability.
- Custom Antibody Services: Tailored solutions for unique research needs, from antigen design to large-scale antibody production.
- Scientific Support: Our in-house technical specialists provide expert guidance to ensure optimal antibody selection and use.
- Sustainable & Ethical Sourcing: We prioritize ethical animal welfare practices and employ recombinant technologies for sustainable antibody production.
Driving Innovation in Antibody Development
Innovation is at the heart of KinesisDx. Our R&D team continuously explores advanced methodologies, including phage display technology, recombinant antibody humanization, and AI-assisted epitope mapping, to develop next-generation antibody reagents.